BIT 2.56% 3.8¢ biotron limited

Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV, page-15

  1. 2,024 Posts.
    lightbulb Created with Sketch. 586
    POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV (BIT225-010)
     Preliminary analyses indicate that the primary objectives of the trial have been met.
    The results suggest that BIT225 is having a unique effect beyond that seen with current standard of
    care antiretroviral drugs.
     The data is consistent with BIT225 targeting virus present in reservoir cells.

 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
-0.001(2.56%)
Mkt cap ! $34.28M
Open High Low Value Volume
3.9¢ 3.9¢ 3.8¢ $1.331K 34.51K

Buyers (Bids)

No. Vol. Price($)
3 605000 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 15483 1
View Market Depth
Last trade - 10.41am 09/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.